Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Total Current Liabilities (2018 - 2025)

Inventiva (IVEVF) posted Total Current Liabilities of $90.1 million for Q4 2025, up 36.12% on a QoQ basis from $66.2 million in Q2 2025, and down 30.18% year-over-year from $129.0 million in Q4 2024.

Analysis

Inventiva (IVEVF) Total Current Liabilities (2018 - 2025) Analysis & Trends

Inventiva has reported Total Current Liabilities for 8 years, with the latest figure at $90.1 million in Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 30.18% year-over-year to $90.1 million in Q4 2025; TTM through Dec 2025 was $90.1 million, a 30.18% decrease from a year earlier, with the FY2025 full-year figure at $90.1 million, down 30.18% from the prior year.
  • Total Current Liabilities was $90.1 million for Q4 2025 at Inventiva, up from $66.2 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $129.0 million in Q4 2024, with the low at $20460.9 in Q2 2024.
  • Average Total Current Liabilities over 5 years is $45.5 million, with a median of $31.3 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities slumped 99.95% in 2024, then jumped 323308.14% in 2025.
  • Over 5 years, Total Current Liabilities stood at $26.1 million in 2021, then gained by 19.81% to $31.3 million in 2022, then jumped by 72.29% to $54.0 million in 2023, then jumped by 139.06% to $129.0 million in 2024, then tumbled by 30.18% to $90.1 million in 2025.
  • The last three Total Current Liabilities figures came in at $90.1 million (Q4 2025), $66.2 million (Q2 2025), and $129.0 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn 54.90 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn 41.64 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn 31.75 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 32.65 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn 37.11 Bn
7 Revolution Medicines 44.11 Bn 44.11 Bn - 354.06 Mn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 1.31 Bn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 607.80 Mn
10 Inventiva 693.72 Mn 693.72 Mn - 90.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 90.07 Mn
Jun 30, 2025 66.17 Mn
Dec 31, 2024 129.01 Mn
Jun 30, 2024 20,460.86
Dec 31, 2023 53.97 Mn
Jun 30, 2023 41.16 Mn
Dec 31, 2022 31.32 Mn
Jun 30, 2022 25.66 Mn
Dec 31, 2021 26.14 Mn
Jun 30, 2021 17.91 Mn
Mar 31, 2021 19.38 Mn
Dec 31, 2020 16.58 Mn
Jun 30, 2020 27.76 Mn
Dec 31, 2019 15.35 Mn
Dec 31, 2018 17.21 Mn